Cleveland BioLabs Inc. (Nasdaq: CBLI) entered a purchase agreement with a
venture capital investor for approximately $25 million. Shares of the
biopharmaceutical more than doubled by leaping $3.93 to $6.76.
Cleveland BioLabs enters purchase agreement
June 25, 2015 at 12:14 PM EDT
